Skip to main content

Want a detailed portfolio tracker?

Telix Pharmaceuticals (TLX) P/E (2024 - 2026)

Telix Pharmaceuticals (TLX) P/E from Nov 14, 2024 to Jul 20, 2026. The TTM Telix Pharmaceuticals (TLX) P/E is -736.08. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Telix Pharmaceuticals (TLX)

YearP/EChange
2026-736.08+40.32%
2025-524.57-333.46%
2024224.70N/A

Comparison Telix Pharmaceuticals (TLX) P/E with competitors

Telix Pharmaceuticals (TLX) P/E is -736.08.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.00%
NBYStablecoin Development Corp0.00-100.00%
ENLVEnlivex Ltd0.07-100.01%
FGENFibroGen Inc0.24-100.03%
CHRSCoherus Biosciences Inc0.85-100.12%
FBIOFortress Biotech Inc0.95-100.13%
ORMPOramed Pharmaceuticals Inc1.50-100.20%
AGENAgenus Inc3.01-100.41%
INVAInnoviva Inc3.15-100.43%
VXRTVaxart Inc3.55-100.48%
CRMDCorMedix Inc3.63-100.49%
CVACCureVac N.V.4.45-100.60%
GLPGGalapagos NV4.86-100.66%
SRPTSarepta Therapeutics Inc4.88-100.66%
ABEOAbeona Therapeutics Inc5.39-100.73%
ABUSArbutus Biopharma Corp5.60-100.76%
ZVRAZevra Therapeutics Inc5.89-100.80%
SPROSpero Therapeutics Inc6.23-100.85%
CGENCompugen Ltd6.31-100.86%
RIGLRigel Pharmaceuticals6.87-100.93%
SLXNSilexion Therapeutics Corp7.30-100.99%
OMEROmeros Corporation9.26-101.26%
AUPHAurinia Pharmaceuticals Inc9.58-101.30%
PLXProtalix BioTherapeutics Inc10.89-101.48%
ACADAcadia Pharmaceuticals Inc11.73-101.59%
TBPHTheravance Biopharma Inc12.26-101.67%
ADMAAdma Biologics Inc12.42-101.69%
HRMYHarmony Biosciences Holdings Inc13.82-101.88%
SABSSAB Biotherapeutics Inc14.14-101.92%
NAGENiagen Bioscience Inc14.82-102.01%
INCYIncyte Corp15.82-102.15%
REGNRegeneron Pharmaceuticals Inc15.86-102.15%
PBYIPuma Biotechnology Inc17.32-102.35%
CPRXCatalyst Pharmaceuticals Inc17.44-102.37%
EXELExelixis Inc17.54-102.38%
TGTXTG Therapeutics Inc18.97-102.58%
MDXGMimedx Group Inc20.55-102.79%
XOMAXOMA Royalty Corp22.87-103.11%
ARGXArgen X SE24.30-103.30%
CTMXCytomX Therapeutics Inc24.82-103.37%
XOMAOXOMA Royalty Corp25.34-103.44%
HALOHalozyme Therapeutics Inc25.62-103.48%
XOMAPXOMA Royalty Corp25.67-103.49%
VRTXVertex Pharmaceuticals Inc27.99-103.80%
RPRXRoyalty Pharma plc - Class A28.69-103.90%
SLNOSoleno Therapeutics Inc29.02-103.94%
ASNDAscendis Pharma A/S30.09-104.09%
LGNDLigand Pharmaceuticals Inc - Class B37.91-105.15%
APLSApellis Pharmaceuticals Inc39.02-105.30%
BMRNBiomarin Pharmaceutical Inc42.21-105.73%
KRYSKrystal Biotech Inc45.34-106.16%
ONCBeiGene Ltd69.54-109.45%
PHARPharming Group N.V.75.03-110.19%
TECHBio-Techne Corp101.96-113.85%
VCELVericel Corp109.92-114.93%
ALNYAlnylam Pharmaceuticals Inc117.96-116.03%
GMABGenmab140.29-119.06%
CORTCorcept Therapeutics Inc212.86-128.92%